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This report attempts to define further the natural history of minor degrees of cervical
dysplasia associated with human papillomavirus (HPV). Five hundred and twenty-five patients
with a diagnosis of mild to moderate cervical dysplasia and HPV effects were followed without
treatment for six months to five years. Those patients who progressed to a greater degree of
dysplasia were removed from follow-up and treated appropriately. Those patients who re-
gressed to anon-dysplastic statewere returned to theoriginal referringphysician tobe followed
with annual cytology. Regression to a non-dysplastic state was 30.5 percent at six months, 50.4
percent at 11/2years, 60.5 percent at2'/2years, 70.9percent at3'/2years, 77.3 percent at41/2years,
7.8 percent have progressed to a greater degree ofcervical dysplasia, removed from follow-up,
and treated, and 22 patients have recurred, all with minor degrees of dysplasia. No invasive
cancer has been diagnosed in this group of patients. From these results, we conclude that
patients with minor degrees of dysplasia associated with HPV can be followed in a routine
screening program with the anticipation that the great majority will, over time, convert to a
non-dysplastic state. A small number of patients will progress to a higher degree of dysplasia
and will be effectively identified, to be referred for colposcopic assessment and appropriate
treatment.
Since Alex Meisels first associated the human papilloma virus (HPV) with cervical
dysplasia [1], there has been an intense interest in the implications of such an
association. This interest hasbecome one ofconcern as a result ofthe observation by
virologists that the "Human PapillomaVirus is necessarybutnotsufficient" [2] to the
development of lower genital tract cancer. These concerns have resulted in the
commonly accepted practice of referring all women with cytologically identified
cervical dysplasia associated with human papillomavirus effects to colposcopy clinics
for confirmation ofdiagnosis and treatment.
Approximately 3 percent ofthe female population ofCanadawho are evercoitally
active will show some degree of cervical cytological atypia (HPV effects or more
significant degrees of dysplasia) on cytological screening (Table 1). Less than 25
percent of those patients will show moderate dysplasia with or without human
papillomavirus effects or more significant degrees ofdysplasia. Before the enormous
cost of colposcopic examination and treatment of this large group of patients with
minor changes can be justified, a clear understanding of the natural history of this
disease state and the ultimate risk of developing greater degrees of dysplasia and
invasive disease is required.
The colposcopy clinic at the Kingston General Hospital (like other colposcopy
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TABLE 1
Combined One Year's Experience (1989) ofThree Canadian Cytological
Laboratories'
n %
Total Smears 134,245
Total Abnormal Smears, including HPV effects 3,967 3
Significant Abnormalities, moderate dysplasia with orwithout
HPV effects or more significant degrees ofdysplasia 930 .7
aDouglas Laboratory, Ottawa, Ontario
MDS Laboratory, Toronto, Ontario
Hotel DieuHospitalLaboratory,Kingston, Ontario
clinics in the early 1980s) noticed a significant change in its referral pattern. The
number ofpatients with significant dysplasia decreased, to be overcompensated by a
large group of patients (usually young) with minor degrees of cervical dysplasia
associated with the human papilloma virus effects. The colposcopic picture was
almost always benign and showed, to this author, little or no evidence to suggest that
these women were at risk of developing greater degrees of dysplasia or invasive
disease.
METHODS
Because ofthis skepticism regarding the implication ofminor degrees ofdysplasia
associated with the human papillomavirus and the paucity ofinformation regarding
the natural history of this state, the colposcopy clinic at the Kingston General
Hospital adopted the followingpractice policy:
1. All patients with mild to moderate dysplasia associated with the human
papillomavirus identified bycytologyorbiopsy atthefirstclinicvisitwouldbe
followed, without treatment, and reviewed at six-monthly intervals.
2. a. Patientswhose degree ofdysplasia progressed to severe dysplasia (with or
withoutpersistent human papillomaviruseffects) orgreater, identified either
by cytology or biopsy, would be removed from follow-up and their lesions
treated appropriately.
b. Patients whose dysplasia disappeared (with or without persistent human
papillomavirus effects), identified bycytologyorbiopsy, wouldbe discharged
to the referring physician with the request that annual cytology be obtained
and the patient be returned to the colposcopy clinic should the dysplasia
recur.
c. Patients demonstrating mild to moderate dysplasia (with or without
persistent human papilloma virus effects), identified by biopsy or cytology,
would be considered unchanged and seen again in sixmonths.
All patients referred to the colposcopy clinic at the Kingston General Hospital
have demonstrated abnormal cervical cytology on a previous routine screening
examination. All patients, at their first visit, had a colposcopic visualization of the
cervix, repeat cytology, and biopsy of any abnormal areas. Patients were enrolled in
this series if they demonstrated the human papilloma virus effects plus mild or
moderate dysplasia either on biopsy or cytology. At each subsequentvisit, the cervix
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Unchanged 17.9%
d reg Regressed 44.2%
Progressed 7.8%
ProtocolViolatIon 109%
TOTAL PATIENTS -525
FIG. 1. Status ofall patients Six months afterclosure ofthe study. All patients were followed for Six to 58
months, with a median follow-up of30 months.
was colposcopically visualized and cytology repeated. Biopsies were taken if there
was concern regarding possible progression ofthe dysplasia.
All cytological smears obtained at the colposcopy clinic, Kingston General Hospi-
tal, were screened by the Cytological Division of the Department of Pathology,
Kingston General Hospital-Queen's University. All biopsies taken at the colpos-
copy clinic were read by the Division of Gynaecologic Oncology, Department of
Pathology, Kingston General Hospital-Queen's University.
Human papilloma virus typingwas not done. The lack ofspecificity in determining
the outcome of minor degrees of dysplasia associated with the human papilloma
virus infection does notjustify the use of such testing on a routine basis [3,4].
This management policy was initiated September 1, 1985, and, for the purpose of
this report, closed December 31, 1989.
RESULTS
Five hundred and twenty-five consecutive patients were enrolled in this series. All
patients were followed for six to 58 months, with a median follow-up of 30 months.
Figure 1 shows the status ofal allpatients sx hafter closure of this series (June
30, 1990). Violations include inappropriate entry into the series, treatment else-
where, and patient request for treatment. Lost are those patients who failed to keep
their last appointments prior to June 30, 1990; many were seen subsequently.
Figure 2 shows the age distribution ofthisgroup. Fiftypercent were under 25 years
of age at the time ofenrollment.
Figure 3 shows the spontaneous regression rate to a non-dysplastic state (with or
without persistent HPV effects) at six-month intervals. The numbers at the top ofthe
bars indicate the total number ofpatients followed to that particular intelval, and the
593JOHN A. CARMICHAEL
40
30t
CL 0~ 201
10
0
20C
71
60
25 n~~~~~~~~~~~ I
2-24 25-2 304 3. 40-44: 46.46 G U > 55
Age Group (Years)
FIG. 2. Age distribution. Numerals at the top ofthe barshow the total numberofpatients in that age
group.
solid portion of the bar indicates the percentage of those patients whose dysplasia
disappeared with orwithout persistent HPV effects.
Figure 4 shows the number and time of recurrences. The frequency of recurrence
appears to decrease with time and at 21/2 years the abnormal cytology rate in this
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FIG. 3. Spontaneous regression to a non-dysplastic state (with orwithout persistent HPV). Numerals at
the top ofthe bar denote the number ofpatients followed to that time period. The solid portion ofthe bar
denotes the percentage that have reverted to a non-dysplastic state.
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FIG. 4. Recurrences. Numerals at the top of the bars indicate the number of patients
cytologically negative (with or without HPV effects) at the beginning of that time interval. The
solid portion indicates the percentage recurring during that period.
population group is about the same as that ofthe population at large. All recurrences
were ofminor degrees, and none required treatment.
Table 2 shows the numberofpatients and time ofprogression to greater degrees of
dysplasia. All patients who progressed were removed from follow-up and effectively
treated. No patient progressed to invasive cancer.
DISCUSSION
The clinicaljustifications for the policyofreferring all patients with minor degrees
of dysplasia associated with human papilloma virus effects to colposcopy clinic for
assessment and possible treatment are:
1. There is a high risk of progression from mild degrees of cervical dysplasia,
associated with the human papilloma virus, to more severe degrees of
dysplasia and even to invasive cancer [4,5].
2. There is a high rate ofcytological undercall of dysplasias associated with the
human papilloma virus effects [6].
TABLE 2
Progressions
Year No.
First 25
Second 12
Third 4
Fourth 0
Total 41
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TABLE 3
Distribution ofAbnormal Smears'
Status No.
HPV only 95
Mild and HPV 206
Mild 650
Moderate and HPV 47
Moderate 170
Severe and HPV 2
Severe 69
Carcinoma in situ and invasive 25
Total smears 43,600
'MDS Laboratories, Toronto, Ontario, 1989
Our experience does not support either of these concepts. As this series matured
year by year, there was an overwhelming tendency for these women to revert
spontaneously to a non-dysplastic state, dispelling the concern over the high risk of
progression to greater degrees of dysplasia and invasive cancer. By the 41/2-year
anniversary date, three-fourths of these patients showed no evidence of dysplastic
change.
The human papillomavirus maybe necessary for the development ofcancer ofthe
cervix, but it is certain that this process is not the common pathway for the greater
majority of women so affected [7]. Clearly some other, less common factor(s) or
co-factor(s) is (are) required for these patients to progress to a greater degree of
dysplasia or invasive cancer.
There were 41 patients who progressed to a more severe degree of dysplasia.
Although the number ofpatients followed decreased with time, the suggestion here
is that progression tends to be early rather than late. There is, of course, the
possibility that some ofthese earlyprogressions were initiallyundercalled at the time
of their entering the series. Regardless of that possibility, the important fact is that
those patients who did show a greater degree of dysplasia were identified in this
dysplastic state before invasive disease developed.
The second concern-cytological undercall-in the presence of human papilloma
virus effects, ifindeed afact, haslittle apparent practical implication, as evidencedby
our experience with this series.
That the human papillomavirus does notmasksignificant dysplasia is suggestedby
the observation of Dr. Meisels [8] that cells showing significant dysplastic change
(while still harboring the virus) tend not to show the cytologic effects of the virus.
This latter observation would appear to be confirmed by the experience of a
moderately sized Canadian cytological laboratory, which in 1989 read 43,600 smears;
96 of these showed a significant degree ofdysplasia (severe or greater) and only two
ofthese had concomitant HPV effects (Table 3)
The high incidence of genital HPV infection in contemporary society [9,10], the
frequency with which this infection is associated with minor degrees of cervical
dysplasia, and the benign colposcopic picture presented bythese patients obliges one
to ask if these minor dysplastic changes associated with the human papilloma virus
seen on cytologic examination are truly dysplastic change or simply "viral effects"
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that disappear when the viral infection itself disappears or, if true dysplasia, that
disappear when the infection disappears?
The fact that over 50 percent ofourpatientswere under 25 yearsofage at the time
oftheir initial colposcopic assessment is inkeepingwith the experience ofothers [11]
and confirms the clinical impression that the human papilloma virus infection (with
or without identifiable dysplastic change) is characteristically seen in the young,
recentlycoitally active population, which, in turn, suggests that the human papilloma
virus, like other virus infections, spontaneously regresses (along with the minor
dysplastic picture) over time, as the individual develops her own defense mechanism.
CONCLUSIONS
Based on these observations and our experience with conservative management,
minor degrees ofdysplasia, over a period of41/2years, we suggest that:
1. Patients with minor degrees of cervical dysplasia associated with human
papilloma virus effects can be confidently followed in a routine screening
program, with the expectation that the overwhelming majoritywill eventually
revert to a non-dysplastic state, and
2. Thosewomenwho do progress to agreater degree ofdysplasia will effectively
be identified in a screening program, to be referred for colposcopic assess-
ment and appropriate treatment.
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